Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-033796
Filing Date
2025-03-05
Accepted
2025-03-05 17:00:08
Documents
2
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1597
2 EX-24 rapp-ex24.htm EX-24 11540
  Complete submission text file 0000950170-25-033796.txt   14610
Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Sevigny Jeffrey (Reporting) CIK: 0001778483 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42121 | Film No.: 25712195

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Issuer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)